• Adverse Reactions of Ensartinib

  Ensartinib is a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC). Common adverse reactions include gastrointestinal symptoms, abno···【Read More】

  Update: 2026-01-15Source: Haiou HealthViews: 83

• Ensartinib Dosage and Administration Instructions

  The recommended usual dose of ensartinib is 225 mg once daily, to be taken orally on an empty stomach (1 hour before a meal or 2 hours after a meal). ···【Read More】

  Update: 2026-01-15Source: Haiou HealthViews: 77

• Is Ensartinib a First, Second, or Third-Generation Targeted Drug?

  Ensartinib is a second-generation anaplastic lymphoma kinase (ALK) targeted drug, primarily indicated for the treatment of ALK-positive non-small cell···【Read More】

  Update: 2026-01-14Source: Haiou HealthViews: 85

• Ensartinib Package Insert

  Ensartinib is an anaplastic lymphoma kinase (ALK)-targeted oral capsule developed by Hutchison MediPharma. It was first approved for marketing in Chin···【Read More】

  Update: 2026-01-14Source: Haiou HealthViews: 93

• 百泽安 (Tislelizumab), PD-1 Inhibitor from BeiGene, Receives 14th Indication Approval in China

  On October 21, 2024, BeiGene announced that 百泽安 (tislelizumab), its anti-PD-1 monoclonal antibody, had been officially approved by the National Medica···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 72

• 百泽安 (Tislelizumab Injection) Approved by the National Medical Products Administration for the Treatm

  On April 11, 2020, BeiGene announced that 百泽安 (generic name: Tislelizumab Injection), an anti-PD-1 antibody drug, had been approved by the National Me···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 77

• BeiGene’s Anti-PD-1 Antibody 百泽安 (Tislelizumab Injection) Receives NMPA Marketing Approval

  On December 28, 2019, BeiGene announced that 百泽安 (generic name: tislelizumab injection), an anti-PD-1 antibody drug, had been approved by the National···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 78

• Under what circumstances should the use of tislelizumab be discontinued immediately?

  If severe discomfort occurs during treatment, contact the attending physician immediately. The physician will assess whether temporary or permanent di···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 78

• Who is strictly prohibited from using tislelizumab?

  Use is contraindicated in pregnant women. As the drug ingredients may affect fetal development through the placenta, women at any stage of pregnancy s···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 77

• What are the dosage forms and specifications of tislelizumab?

  100 mg per vial (equivalent to 100 mg of active ingredient per vial).【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 83

• Can the medication be used if it has expired or the outer packaging is damaged?

  No. The medication may lose its efficacy and even cause adverse reactions.【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 74

• What dietary precautions should be taken during medication?

  A light diet is recommended. Avoid spicy and greasy foods, and choose easily digestible foods.【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 72

• How Much Does One Vial of Tislelizumab Cost?

  The price of tislelizumab varies by region, hospital grade, medical insurance policy and purchasing channel. A single vial (100mg/vial) generally cost···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 74

• Price of Tislelizumab

  Tislelizumab is an anti-tumor drug of the PD-1 inhibitor class, mainly used for the treatment of a variety of solid tumors and hematological malignanc···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 77

• Contraindications for tislelizumab use

  Tislelizumab (a PD-1 inhibitor) is contraindicated mainly in patients with hypersensitivity to the drug components, active autoimmune diseases, uncont···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 83